GlaxoSmithKline, Pfizer join to fight HIV

Filed under: Company News When we hear of pharmaceutical companies’ ventures it’s usually either a straight merger & acquisition or a collaboration on a drug or two in their pipelines to share costs and, of course, potential profits. But Pfizer Inc. ( PFE ) and GlaxoSmithKline ( GSK ) have come up with a new one. Rather than merge (recall, Pfizer is acquiring Wyeth for $68 billion), or collaborate

on a drug or two, the two have decided to merge their HIV operations . They plan to develop a company focused solely on research, development and commercialization of HIV medicines. Continue reading GlaxoSmithKline, Pfizer join to fight HIV GlaxoSmithKline, Pfizer join to fight HIV originally appeared on DailyFinance on Fri, 17 Apr 2009 16:00:00 EST. Money.Finance|Finance|Finance

More:
GlaxoSmithKline, Pfizer join to fight HIV